Genethon in the media

RSS feed

Genethon becomes the first not-for-profit pharmaceutical laboratory (MyPharma editions)

The Telethon laboratory is now authorized to produce medicines (Sante magasine)

After two years of waiting, Genethon BioProd is finally certified as a pharmaceutical manufacturer (

La Gazette du Laboratoire

Genethon BioProd : A manufacturing capacity for gene therapy products which is unique in the world

Read the article [PDF in FRENCH – 360 Ko]

Author : S. Denis

For more information

La Gazette du Laboratoire

New challenges for AFM-Telethon with the launch of the Biotherapies Institute for Rare Diseases which includes Genethon.

Read the article [PDF in FRENCH – 400 Ko]

For more information

Nature Medicine

Gene therapies advance, but some see manufacturing challenges

“Gene therapy has traveled a long and winding road to the clinic. The field famously hit a major roadblock 13 years ago when the teenager Jesse Gelsinger suffered a fatal immune reaction in response to a gene therapy product designed to correct his rare liver disease, leading to a perception…”

Author : Elie Dolgin

 Read on website

Industrie Pharma

Genethon takes on more projects

Read the article [PDF IN FRENCH – 561 ko]

Non-profit Drugs: a first in France!

Thanks to a new decree, “Drugs for innovative therapy”, Genethon, the AFM-Telethon laboratory, will be able to commercialize products from its research. A first in the non-profit arena.

Author(s) : – E.Dal’Secco

Read the article [PDF – 18,7 ko]

“Drugs for innovative therapies”: a new step for AFM-Telethon and its Genethon laboratory.

Read the article [PDF – 21,4 ko]


Gene Therapy: The industrial era begins

Read the article [PDF in French – 764ko]